Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVKJQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,925
Award facts
- Contract value 100% obligated
- $28,925.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,925.09 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma in military and federal healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen maintains an extensive portfolio of delivery orders through this IDC vehicle, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and the Defense Health Agency. The company's demonstrated capability to compete for and fulfill federal procurement requirements positions it as a strategic vendor within the DLA medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FVKJQ?
SPE2DB25FVKJQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FVKJQ worth?
The government has obligated $28,925 on SPE2DB25FVKJQ.
Is contract SPE2DB25FVKJQ an order under another contract?
Yes. SPE2DB25FVKJQ is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKJQ competed?
The extent of competition for SPE2DB25FVKJQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award